Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pulse Biosciences CS (PLSE)

Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pulse Biosciences CS 3957 POINT EDEN WAY HAYWARD CA 94545 USA

www.pulsebiosciences.com P: 510-906-4600

Description:

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.

Key Statistics

Overview:

Market Capitalization, $K 881,391
Enterprise Value, $K 837,021
Shares Outstanding, K 55,225
Annual Sales, $ 0 K
Annual Net Income, $ -42,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,140 K
EBIT, $ -44,630 K
EBITDA, $ -43,420 K
60-Month Beta 1.75
% of Insider Shareholders 71.50%
% of Institutional Shareholders 76.95%
Float, K 15,739
% Float 28.50%
Short Volume Ratio 0.32

Growth:

1-Year Return 152.93%
3-Year Return -17.95%
5-Year Return 34.45%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 61.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 05/07/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -0.78
EPS Growth vs. Prev Qtr 19.05%
EPS Growth vs. Prev Year 32.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PLSE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -86.15%
Return-on-Assets % -66.87%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 27.70
Book Value/Share 0.66
Interest Coverage -1.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar